The premier global healthcare event MEDICA 2025 successfully convened and concluded in Düsseldorf, Germany from Nov 17 to 20. YZY Med made a striking appearance with multiple products, joining industry leaders worldwide to celebrate this landmark occasion and further cementing its brand’s international expansion.
At the exhibition, YZY Med prominently launched its comprehensive portfolio, including cardiovascular pharmacogenomics kits, tumour-targeted companion diagnostics kits, CTCBIOPSY CTC Separatr, and Fully automated FISH slide processing system F902. This showcase demonstrated the company’s profound capabilities and innovative achievements in precision medicine, attracting significant attention and sparking industry interest. Successful procurement agreements were secured with clients from Europe, Asia, Africa, and South America.
This successful participation at MEDICA in Germany marks a pivotal step in YZY Med’s global brand expansion. Moving forward, the company will remain innovation-driven, advancing precision medicine technologies to inject fresh vitality into global healthcare endeavours.